BlackRock (BLK) Replacing Genzyme (GENZ) in S&P 500
Tweet
Share
E-mail
Get Alerts BLK Hot Sheet
Price: $1,107.08 --0%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: +30.5%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: +30.5%
Join SI Premium – FREE
BlackRock Inc. (NYSE: BLK) will replace Genzyme Corp. (NASDAQ: GENZ) in the S&P 500 index after the close of trading on Friday, April 1, 2011. S&P Global 1200 constituent Sanofi-aventis (NYSE: SNY) is acquiring Genzyme in a deal expected to be completed soon, pending final conditions.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- salesforce.com (CRM) Reiterated at Market Outperform by Citizens
- Baird Reiterates Outperform Rating on S&P Global (SPGI)
- Global S&P Futures mixed to lower in premarket
Create E-mail Alert Related Categories
Corporate News, Trader TalkRelated Entities
Standard & Poor's, Genzyme/Sanofi-AventisSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
